Referenser

  1. Ajne G BM, Carlsson Y. Obstetrik: Studentlitteratur AB; 2021.

  2. Developing New Pharmaceutical Treatments for Obstetric Conditions. RCOG. [Available from: https://www.rcog.org.uk/media/x10h1af1/sip-50.pdf

  3. FASS 2025 [Available from: https://www.fass.se/LIF/startpage?userType=0

  4. Briggs CG FR, Yaffe SJ. Introduction. Drugs in pregnancy and lactation. 8 ed: Lippincott, Williams and Wilkins; 2008.

  5. Janusinfo. Läkemedel och fosterskador: Stockholms läns landsting; 2025 [Available from: https://janusinfo.se

  6. Svelic. Oberoende evidensbaserad läkemedelsinformation för sjukvården. [Available from: https://svelic.se/

  7. Relis. Produsentuavhengig legemiddelinformasjon for helsepersonell 2025 [Available from: https://svelic.se/

  8. Livsmedelsverket. Ät folsyra innan du blir gravid 2020 [Available from: https://www.livsmedelsverket.se/om-oss/publikationer/artiklar/2020/l-2020-nr-09-folatfolsyra-fore-och-under-graviditet

  9. Wilson RD, Genetics C, Wilson RD, Audibert F, Brock JA, Carroll J, et al. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies. J Obstet Gynaecol Can. 2015;37(6):534-52.

  10. Roth C, Magnus P, Schjolberg S, Stoltenberg C, Suren P, McKeague IW, et al. Folic acid supplements in pregnancy and severe language delay in children. JAMA. 2011;306(14):1566-73.

  11. Lindroos L, Korsoski R, Ohman MO, Elden H, Karlsson O, Sengpiel V. Improving assessment of acute obstetric patients - introducing a Swedish obstetric triage system. BMC Health Serv Res. 2021;21(1):1207.

  12. Fejzo MS, Trovik J, Grooten IJ, Sridharan K, Roseboom TJ, Vikanes A, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019;5(1):62.

  13. Asker C, Norstedt Wikner B, Kallen B. Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol. 2005;61(12):899-906.

  14. Jansen LAW, Koot MH, Van't Hooft J, Dean CR, Bossuyt PMM, Ganzevoort W, et al. The windsor definition for hyperemesis gravidarum: A multistakeholder international consensus definition. Eur J Obstet Gynecol Reprod Biol. 2021;266:15-22.

  15. Fejzo M, Rocha N, Cimino I, Lockhart SM, Petry CJ, Kay RG, et al. GDF15 linked to maternal risk of nausea and vomiting during pregnancy. Nature. 2024;625(7996):760-7.

  16. Oudman E, Wijnia JW, Oey M, van Dam M, Painter RC, Postma A. Wernicke's encephalopathy in hyperemesis gravidarum: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2019;236:84-93.

  17. Behandling av extremt graviditetsillamående (hyperemesis gravidarum). SBU rapport 2022 2022 [Available from: https://www.sbu.se/355

  18. Oudman E, Wijnia JW, Oey M, van Dam M, Painter RC, Postma A. Wernicke's encephalopathy in hyperemesis gravidarum: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2019;236:84-93.

  19. Zhang R, Persaud N. 8-Way Randomized Controlled Trial of Doxylamine, Pyridoxine and Dicyclomine for Nausea and Vomiting during Pregnancy: Restoration of Unpublished Information. PLoS One. 2017;12(1):e0167609.

  20. Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S228-31.

  21. Trottier M, Erebara A, Bozzo P. Treating constipation during pregnancy. Can Fam Physician. 2012;58(8):836-8.

  22. Kartläggning av metoder för diagnostik och behandling av graviditetskomplikationen graviditetsrelaterad bäckensmärta. SBU rapport 2022. 2022 [Available from: https://www.sbu.se/sv/publikationer/sbu-kartlagger/kartlaggning-av-metoder-for-diagnostik-och-behandling-av-graviditetskomplikationen-graviditetsrelaterad-backensmarta/

  23. Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001;322(7281):266-70.

  24. Dathe K, Hultzsch S, Pritchard LW, Schaefer C. Risk estimation of fetal adverse effects after short-term second trimester exposure to non-steroidal anti-inflammatory drugs: a literature review. Eur J Clin Pharmacol. 2019;75(10):1347-53.

  25. Hernandez-Diaz S, Garcia-Rodriguez LA. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Am J Med. 2001;110 Suppl 3A:20S-7S.

  26. Souter D, Harding J, McCowan L, O'Donnell C, McLeay E, Baxendale H. Antenatal indomethacin--adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol. 1998;38(1):11-6.

  27. Aube M. Migraine in pregnancy. Neurology. 1999;53(4 Suppl 1):S26-8.

  28. Spielmann K, Kayser A, Beck E, Meister R, Schaefer C. Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study. Cephalalgia. 2018;38(6):1081-92.

  29. Kallen B, Nilsson E, Otterblad Olausson P. Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. Drug Saf. 2011;34(8):691-703.

  30. Yakoob MY, Bateman BT, Ho E, Hernandez-Diaz S, Franklin JM, Goodman JE, et al. The risk of congenital malformations associated with exposure to beta-blockers early in pregnancy: a meta-analysis. Hypertension. 2013;62(2):375-81.

  31. Lennestal R, Otterblad Olausson P, Kallen B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol. 2009;65(6):615-25.

  32. Uktis. Use of beta-adrenoreceptor blocking drugs (beta-blockers) in pregnancy. Uktis  [Available from: https://uktis.org/monographs/use-of-beta-adrenoceptor-blocking-drugs-beta-blockers-in-pregnancy/

  33. Hypertonisjukdomar under graviditet. SFOG 2019 [Available from: https://www.sfog.se/media/337263/hypertonisjukdomar-under-graviditet-sfog-2019-10-23-reviderad-210121.pdf

  34. Riktlinjer för hypertonisjukdomar under graviditet. SFOG 2023 [Available from: https://www.sfog.se/media/338533/pe-riktlinje-230214.pdf

  35. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007(2):CD004659.

  36. ACOG. Antenatal Corticosteroid Therapy for Fetal Maturation 2025 [Available from: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/antenatal-corticosteroid-therapy-for-fetal-maturation

  37. Barnläkarföreningen. Nationella riktlinjer extrem förtidsbörd 2024 [Available from: http;//neo.barnlakarforeningen.se/wp-content/uploads/sites/14/2024/04/Nationella-riktlinjer-extrem-fortidsbörd-apr-24-FINAL.pdf

  38. Socialstyrelsen. Statistik om graviditeter, förlossningar och nyfödda barn 2022 2023 [Available from: https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/statistik/2023-12-8867.pdf

  39. Tyroideasjukdom i samband med graviditet. SFOG 2004 [Available from: https://www.sfog.se/start/soek/?q=Tyreoideasjukdom%20i%20samband%20med%20graviditet%20200408

  40. Riktlinjer och rekommendationer från svensk reumatologisk förening  [Available from: https://riktlinjer.svenskreumatologi.se/riktlinjer-och-rekommendationer/rekommendationer-avseende-anti-inflammatorisk-och-immun-modulerande-behandling-i-samband-med-graviditet-och-amning-arbetsfil

  41. The European Alliance of Associations for Rheumatology, EULAR  [Available from: https://www.eular.org/recommendations-home

  42. Information om vaccinationer från Folkhälsomyndigheten  [Available from: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/

  43. INF PREG. Kunsapscentrum för infektioner under graviditeten.  [Available from: https://www.medscinet.se/infpreg/

  44. Naver L, Albert J, Carlander C, Flamholc L, Gisslen M, Karlstrom O, et al. Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017. Infect Dis (Lond). 2018;50(7):495-506.

  45. European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370-98.

  46. SFOG råd: Hemostas.  [Available from: https://www.sfog.se/start/kunskapsstoed/obstetrik/hemostas

  47. Psykisk sjukdom i samband med graviditet och spädbarnsperiod - Kunskapsstöd för vårdgivare  [Available from: https://kunskapsstodforvardgivare.se/omraden/psykisk-halsa/regionala-vardprogram/psykisk-sjukdom-i-samband-med-graviditet-och-spadbarnsperiod

  48. SBU. Psykologisk behandling av postpartumdepression. SBU rapport 2022. 2022 [Available from: https://www.sbu.se/sv/publikationer/SBU-utvarderar/psykologisk-behandling-av-postpartumdepression/

  49. SFOG. Barnafödande och psykisk sjukdom. SFOG 2009 [Available from: https://www.sfog.se/natupplaga/nr6236bd81d5-ea78-49da-a6c3-0de985b88f5c.pdf

  50. barnhälsovård Ri. EPDS-formulär, Rikshandboken i barnhälsovård  [Available from: https://www.rikshandboken-bhv.se/metoder--riktlinjer/screening-med-epds/epds-formular/

  51. Läkemedelsverket. Läkemedel vid depression, ångestsyndrom och tvångssyndrom hos barn och vuxna - behandlings­rekommendation från Läkemedelsverket 2016 [Available from: https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/behandlingsrekommendationer/sok-behandlingsrekommendationer/lakemedel-vid-depression-angestsyndrom-och-tvangssyndrom-hos-barn-och-vuxna---behandlingsrekommendation

  52. Folkhälsomyndigheten. Vaccinationer för dig som är gravid. 2025 [Available from: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/o/om-vaccinationer-for-dig-som-ar-gravid/

  53. InfPreg Vaccinationer. 2025 [Available from: https://www.medscinet.se/infpreg/healthcareinfoMore.aspx?topic=31

Föregående sida
För vidare läsning

Nästa sida
Tillbaka till kapitlets första sida